• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cue Biopharma Inc (NQ: CUE )

    1.790 +0.010 (+0.56%)
    Streaming Delayed Price Updated: 11:48 AM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cue Biopharma Inc

    < Previous 1 2 3 4 5 Next >
    Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    7 Hot Growth Stocks Poised to Triple in 2023
    These hot growth stocks to buy can triple in price in 2023, with some holding impressive upside that's much higher. 
    Via InvestorPlace
    7 High-Potential Penny Stocks in the Biotech Sector
    Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider. 
    Via InvestorPlace
    Cue Biopharma Welcomes Seasoned Pharmaceutical Executive Pamela D. Garzone, Ph.D., to its Board of Directors
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Earnings Perspective: Return On Capital Employed
    Via Benzinga
    Cue Biopharma's Earnings Outlook
    Via Benzinga
    Cue Biopharma Welcomes Industry Veteran Mr. Patrick Verheyen to its Board of Directors
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 21, 2023
    Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. 
    Via Benzinga
    Cue Biopharma to Host Business Update Call and Webcast
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma to Present at Two March 2023 Investor Healthcare Conferences
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Enters into a Strategic Collaboration and Option Agreement with Ono Pharmaceutical for CUE-401
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma’s Therapeutic Immuno-STAT Biologics to be Featured in Oxford University Presentation at the 67th Biophysical Society Annual Meeting
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Announces the Appointment of Dr. Rafi Ahmed to its Scientific Advisory Board
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma to Present at Two February 2023 Scientific Conferences
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Announces Chief Medical Officer Transition
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Public Ventures LLC Completes First Public Company Financing as a Broker-Dealer for Cue Biopharma, Inc. (Nasdaq:CUE)
    Via ACCESSWIRE
    Cue Biopharma Reports Third Quarter 2022 Financial Results
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Presents New Positive Data from Ongoing Phase 1 Trial of CUE-101 in Combination with KEYTRUDA(R) for Recurrent/Metastatic HPV+ Head and Neck Cancer at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma to Host Business Update Call and Webcast
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Good morning, traders! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning! 
    Via InvestorPlace
    Why Soluna Holdings Shares Are Trading Sharply Lower; Here Are 38 Stocks Moving Premarket
    Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) rose 70.8% to $0.41 in pre-market trading. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation. 
    Via Benzinga
    Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers 
    Via Benzinga
    Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. 
    Via Benzinga
    Cue Biopharma Granted FDA Fast Track Designation for CUE-101 for the Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
      
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.